NO178056C - Fremgangsmåte ved fremstilling av et farmasöytisk preparat med forbedret absorpsjon, toleranse og/eller retensjonshastighet - Google Patents

Fremgangsmåte ved fremstilling av et farmasöytisk preparat med forbedret absorpsjon, toleranse og/eller retensjonshastighet

Info

Publication number
NO178056C
NO178056C NO902132A NO902132A NO178056C NO 178056 C NO178056 C NO 178056C NO 902132 A NO902132 A NO 902132A NO 902132 A NO902132 A NO 902132A NO 178056 C NO178056 C NO 178056C
Authority
NO
Norway
Prior art keywords
tolerance
preparing
organic anions
pharmaceutical composition
retention rate
Prior art date
Application number
NO902132A
Other languages
English (en)
Other versions
NO178056B (no
NO902132L (no
NO902132D0 (no
Inventor
Richard G Markham
Original Assignee
Oxycal Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/246,504 external-priority patent/US4968716A/en
Priority claimed from PCT/US1989/001642 external-priority patent/WO1990012571A1/en
Application filed by Oxycal Lab Inc filed Critical Oxycal Lab Inc
Publication of NO902132L publication Critical patent/NO902132L/no
Publication of NO902132D0 publication Critical patent/NO902132D0/no
Priority to NO19944971A priority Critical patent/NO311219B1/no
Publication of NO178056B publication Critical patent/NO178056B/no
Publication of NO178056C publication Critical patent/NO178056C/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • A61K31/375Ascorbic acid, i.e. vitamin C; Salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
NO902132A 1988-09-19 1990-05-14 Fremgangsmåte ved fremstilling av et farmasöytisk preparat med forbedret absorpsjon, toleranse og/eller retensjonshastighet NO178056C (no)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO19944971A NO311219B1 (no) 1988-09-19 1994-12-21 Fremgangsmåte for fremstilling av et preparat med forbedret vitamin C-aktivitet

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US07/246,504 US4968716A (en) 1987-04-10 1988-09-19 Compositions and methods for administering therapeutically active compounds
PCT/US1989/001642 WO1990012571A1 (en) 1989-04-07 1989-04-07 Compositions and methods for administering vitamin c
PCT/US1989/004046 WO1990003167A1 (en) 1988-09-19 1989-09-15 Compositions and methods for administering therapeutically active compounds

Publications (4)

Publication Number Publication Date
NO902132L NO902132L (no) 1990-05-14
NO902132D0 NO902132D0 (no) 1990-05-14
NO178056B NO178056B (no) 1995-10-09
NO178056C true NO178056C (no) 1996-01-17

Family

ID=22930954

Family Applications (1)

Application Number Title Priority Date Filing Date
NO902132A NO178056C (no) 1988-09-19 1990-05-14 Fremgangsmåte ved fremstilling av et farmasöytisk preparat med forbedret absorpsjon, toleranse og/eller retensjonshastighet

Country Status (16)

Country Link
EP (1) EP0417209B1 (no)
JP (1) JP2973365B2 (no)
AT (1) ATE160939T1 (no)
CA (1) CA1341434C (no)
DE (1) DE68928488T2 (no)
DK (1) DK175783B1 (no)
FI (1) FI97950C (no)
HU (1) HU905911D0 (no)
NO (1) NO178056C (no)
NZ (1) NZ230700A (no)
PL (1) PL165416B1 (no)
RO (1) RO108148B1 (no)
RU (1) RU2059410C1 (no)
WO (1) WO1990003167A1 (no)
YU (1) YU47746B (no)
ZA (1) ZA904494B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2310941T3 (es) * 1999-08-30 2009-01-16 The Ester C Company Utilizaciones y composiciones para la quimioterapia selectiva destinada al cancer.
AT501682A1 (de) 2005-01-14 2006-10-15 Hermine Dr Engl Verfahren zur herstellung einer wirkstoffmischung
FI20095278A0 (fi) 2009-03-18 2009-03-18 Valtion Teknillinen Ksylonihapon valmistus
KR101037125B1 (ko) * 2009-05-14 2011-05-26 계명대학교 산학협력단 바이오에탄올 생산을 위한 바이오매스 전처리법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2606903A (en) * 1944-03-29 1952-08-12 Physiological Chemicals Compan Ascorbic acid addition compound of sulfathiazole
US2822317A (en) * 1955-12-12 1958-02-04 Smith Kline French Lab Aqueous iron-ascorbic acid preparation
GB2040164A (en) * 1979-01-31 1980-08-28 Beecham Group Ltd Compositions containing paracetamol
US4822816A (en) * 1987-04-10 1989-04-18 Oxycal Laboratories, Inc. Compositions and methods for administering vitamin C

Also Published As

Publication number Publication date
FI97950C (fi) 1997-03-25
JP2973365B2 (ja) 1999-11-08
JPH03504502A (ja) 1991-10-03
DK124290D0 (da) 1990-05-18
NO178056B (no) 1995-10-09
RU2059410C1 (ru) 1996-05-10
EP0417209A1 (en) 1991-03-20
YU47746B (sh) 1996-01-08
DE68928488D1 (de) 1998-01-22
CA1341434C (en) 2003-07-08
YU117890A (sh) 1993-10-20
NO902132L (no) 1990-05-14
PL165416B1 (pl) 1994-12-30
RO108148B1 (ro) 1994-02-28
WO1990003167A1 (en) 1990-04-05
HU905911D0 (en) 1991-03-28
NO902132D0 (no) 1990-05-14
AU621672B2 (en) 1992-03-19
AU4328889A (en) 1990-04-18
ZA904494B (en) 1991-03-27
FI902461A0 (fi) 1990-05-18
NZ230700A (en) 1992-07-28
EP0417209B1 (en) 1997-12-10
ATE160939T1 (de) 1997-12-15
EP0417209A4 (en) 1992-01-08
FI97950B (fi) 1996-12-13
DE68928488T2 (de) 1998-04-02
DK124290A (da) 1990-05-18
DK175783B1 (da) 2005-02-21

Similar Documents

Publication Publication Date Title
JPS56135418A (en) Heat treatment of aqueous solution containing 8 factor of coagulation of blood derived from human
AU576365B2 (en) Collagen and or fibrinogen as carrier of drugs for their introduction into cellular lesion areas
SE8402549D0 (sv) Substituerade moranolinderivat
IE780643L (en) THERAPEUTIC APPLICATION OF d, 1-CARNITINE DERIVITIVES
AU1331588A (en) Method for treatment of alcohol abuse
WO1996024370B1 (en) Pharmaceutical non inorganic saline solutions for endonasal administration of a calcitonin
DE3786893D1 (de) Piperidinderivat zur schmerzbehandlung.
DK0668077T3 (da) Produkter, som indeholder G-CSF og TNF-bindende protein
IL90056A (en) Topical pharmaceutical compositions containing 4-quinoline carboxylic acid derivatives
JPS56106594A (en) Stabilizing method of plasminogen
CA1289885C (en) Tissue growth regulation
NO178056C (no) Fremgangsmåte ved fremstilling av et farmasöytisk preparat med forbedret absorpsjon, toleranse og/eller retensjonshastighet
HUT57204A (en) Process for producing 4-fluoro-2-///4-methoxy-2-pyridinyl/-methyl/-sulfinyl/-1h-benzimidazol with gastric acid secration-diminishing activity and pharmaceutical compositions containing them
RU2001118854A (ru) Оптически активное производное пиридил-4н-1,2,4-оксадиазина и его применение при лечении сосудистых заболеваний
IE44339L (en) Piperazine derivatives.
CA1215323A (en) Curative composition for buerger's disease
NO893256D0 (no) Fremgangsmaate for fremstilling av furyltiazolderivater.
DE3276786D1 (en) Medical process and preparation
DK15088A (da) Antibakterielt lyofiliseret praeparat
JPS643123A (en) Remedy for skin inflammation
IE873463L (en) Compositions
KR890001555A (ko) 요산 배설용 조성물
RU98111356A (ru) Способ лечения ожогового шока
HUT50438A (en) Process for production of medical compositions containing as active substance 2-/2-methil-4-chlor-phenilimin/-imidasolidine
KR900701265A (ko) 치료활성제(Therapeutically active compounds) 투여에 관한 방법과 그에 대한 조성물

Legal Events

Date Code Title Description
MK1K Patent expired